MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
Go back to MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)| (NASDAQ: MGTX) | Delayed: 13.26 -0.27 (2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.53 | 52 Week High | $ | |||
| Open | $13.40 | 52 Week Low | $ | |||
| Day High | $13.76 | P/E | N/A | |||
| Day Low | $13.25 | EPS | $ | |||
| Volume | 534,315 | |||||
| (NASDAQ: MGTX) | Delayed: 13.26 -0.27 (2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.53 | 52 Week High | $ | |||
| Open | $13.40 | 52 Week Low | $ | |||
| Day High | $13.76 | P/E | N/A | |||
| Day Low | $13.25 | EPS | $ | |||
| Volume | 534,315 | |||||

